These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16882888)

  • 1. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy.
    Rajan S; Williams SS; Jagatheesan G; Ahmed RP; Fuller-Bicer G; Schwartz A; Aronow BJ; Wieczorek DF
    Physiol Genomics; 2006 Nov; 27(3):309-17. PubMed ID: 16882888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.
    Rajan S; Pena JR; Jegga AG; Aronow BJ; Wolska BM; Wieczorek DF
    Physiol Genomics; 2013 Sep; 45(17):764-73. PubMed ID: 23800848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.
    Gaffin RD; Chowdhury SA; Alves MS; Dias FA; Ribeiro CT; Fogaca RT; Wieczorek DF; Wolska BM
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1646-55. PubMed ID: 21743000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.
    Schulz EM; Wilder T; Chowdhury SA; Sheikh HN; Wolska BM; Solaro RJ; Wieczorek DF
    J Biol Chem; 2013 Oct; 288(40):28925-35. PubMed ID: 23960072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
    Michele DE; Gomez CA; Hong KE; Westfall MV; Metzger JM
    Circ Res; 2002 Aug; 91(3):255-62. PubMed ID: 12169652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of plasma membrane Ca(2+)-ATPase isoform 4 prevents development of hypertrophy in a model of hypertrophic cardiomyopathy.
    Prasad V; Lorenz JN; Lasko VM; Nieman ML; Jiang M; Gao X; Rubinstein J; Wieczorek DF; Shull GE
    J Mol Cell Cardiol; 2014 Dec; 77():53-63. PubMed ID: 25280781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
    Muthuchamy M; Pieples K; Rethinasamy P; Hoit B; Grupp IL; Boivin GP; Wolska B; Evans C; Solaro RJ; Wieczorek DF
    Circ Res; 1999 Jul; 85(1):47-56. PubMed ID: 10400910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.
    Prabhakar R; Petrashevskaya N; Schwartz A; Aronow B; Boivin GP; Molkentin JD; Wieczorek DF
    Mol Cell Biochem; 2003 Sep; 251(1-2):33-42. PubMed ID: 14575301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF
    J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.
    Sheehan KA; Arteaga GM; Hinken AC; Dias FA; Ribeiro C; Wieczorek DF; Solaro RJ; Wolska BM
    J Mol Cell Cardiol; 2011 Mar; 50(3):442-50. PubMed ID: 21047515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.
    Peña JR; Szkudlarek AC; Warren CM; Heinrich LS; Gaffin RD; Jagatheesan G; del Monte F; Hajjar RJ; Goldspink PH; Solaro RJ; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2010 Dec; 49(6):993-1002. PubMed ID: 20854827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
    Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
    Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.
    Wilder T; Ryba DM; Wieczorek DF; Wolska BM; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1720-30. PubMed ID: 26432840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity.
    Bottinelli R; Coviello DA; Redwood CS; Pellegrino MA; Maron BJ; Spirito P; Watkins H; Reggiani C
    Circ Res; 1998 Jan 9-23; 82(1):106-15. PubMed ID: 9440709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
    J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.